Sonia T. Oskouei, PharmD

Sonia T. Oskouei, PharmD, BCMAS, DPLA, is the vice president of Biosimilars for Cardinal Health. Within the global healthcare company, she has the unique role of leading the biosimilars strategy across the Pharmaceutical Distribution and Specialty Solutions businesses on behalf of health care providers worldwide.
Cardinal Health Specialty Solutions has produced a Rheumatology Insights report that includes results from a survey of over 100 US-based rheumatologists on their perceptions and experiences with biosimilars in rheumatology thus far.
Jul 4, 2020 @11:00 AM
The topic of interchangeability continues to draw debate when it comes to biosimilars, as perceptions on its value and market impact vary per stakeholder. Here are 9 things to consider when examining biosimilar interchangeability.
Apr 2, 2018 @05:54 PM
As part of the final CY2018 Medicare Physician Fee Schedule (PFS) policy, biosimilars will each have unique Healthcare Common Procedure Coding System (HCPCS) codes and payments under Medicare Part B, starting January 1, 2018.
Nov 16, 2017 @02:33 PM
The European Union, considered the most seasoned user of biosimilars, has approved the highest number of biosimilars worldwide.
Oct 11, 2017 @01:52 PM

Click here to view Biosimilars CME Activities

Click here to view Biosimilars PTCE Activities

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars® is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2020 Intellisphere, LLC. All Rights Reserved.